fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Benzodiazepines appear to pose miscarriage risk

Written by | 3 Jan 2024

Researchers from a Taiwanese study report that an increase in the risk of miscarriage is associated with benzodiazepine use during pregnancy, after adjustments for cofounders. The findings appeared… read more.

AI may aid in diagnosing adolescents with ADHD

Written by | 2 Dec 2023

Using artificial intelligence (AI) to analyze specialized brain MRI scans of adolescents with and without attention-deficit/hyperactivity disorder (ADHD), researchers found significant differences in nine brain white matter tracts… read more.

Number of dementia cases could be 42% higher than previously estimated by 2040

Written by | 29 Oct 2023

Up to 1.7 million people could be living with dementia in England and Wales by 2040 – over 40% more than previously forecast – finds a new UCL-led… read more.

Simple blood test can help diagnose bipolar disorder

Written by | 28 Oct 2023

Researchers have developed a new way of improving diagnosis of bipolar disorder that uses a simple blood test to identify biomarkers associated with the condition. The researchers, from… read more.

Clinical trial demonstrates benefits of solriamfetol for adults with ADHD

Written by | 12 Oct 2023

Although several medications are approved to treat attention-deficit/hyperactivity disorder (ADHD), some individuals experience limited benefits from the drugs or develop side effects from their use. A recent clinical… read more.

New blood test gives very high accuracy to screen for Alzheimer’s disease

Written by | 2 Sep 2023

A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude… read more.

Young men at highest risk of schizophrenia linked with cannabis use disorder

Written by | 8 May 2023

Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the… read more.

Online tool found to be effective at assessing dementia risk

Written by | 24 Apr 2023

Researchers at UNSW Sydney and Neuroscience Research Australia (NeuRA) have developed and evaluated a tool for assessing dementia risk, with promising initial results. Currently, over 55 million people are living with dementia… read more.

Vitamin D supplementation appears to reduce dementia incidence

Written by | 16 Mar 2023

Researchers at the University of Calgary in Canada and the University of Exeter in the United Kingdom explored the relationship between vitamin D supplementation and dementia in more… read more.

New research points to drug option for hair-pulling, skin-picking disorders

Written by | 10 Mar 2023

New research at the University of Chicago Medicine has found that a drug commonly used to treat symptoms of Alzheimer’s disease effectively reduced symptoms of adults who experience… read more.

Social isolation linked to neurodegeneration

Written by | 6 Feb 2023

Social lifestyle determinants, including social isolation, are associated with neurodegeneration risk factors, according to a new study published PLOS ONE by scientists at McGill University, Canada. Alzheimer’s disease (AD) is… read more.

Ketamine found to increase brain noise

Written by | 30 Dec 2022

An international team of researchers including Sofya Kulikova, Senior Research Fellow at the HSE University-Perm, found that ketamine, being an NMDA receptor inhibitor, increases the brain’s background noise, causing higher… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.